» Articles » PMID: 11339819

Laminin-10 Mediates Basal and EGF-stimulated Motility of Human Colon Carcinoma Cells Via Alpha(3)beta(1) and Alpha(6)beta(4) Integrins

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 2001 May 8
PMID 11339819
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Signals from the epidermal growth factor (EGF) receptor and integrin-dependent adhesion to laminin contribute to the progression and metastasis of colonic tumors. However, little is know about the mechanisms by which these signals cooperate. Recently, we have reported that the colon cancer cell line LIM1215 secretes and adhere to autocrine laminin-10 via multiple integrin receptors and that EGF stimulates spreading of these cells on the same substrate. In this report, we investigate the effect of EGF and laminin-10 on colon cancer cell migration in vitro. EGF stimulates migration of LIM1215 cells in a wound healing assay. The response to EGF is inhibited by anti-EGF receptor antibody 528, the EGF receptor kinase inhibitor AG-1478, or the MAP kinase kinase inhibitor PD98059 but not the PI3-K inhibitor wortmannin. Using Transwell migration chambers, we demonstrate that laminin-10 but not collagen-I, collagen-IV, or a commercial preparation of human placental laminin is a potent motility factor for LIM1215 cells. The migration response to laminin-10 is increased upon stimulation of the cells with EGF and correlates with the up-regulation of alpha(6)beta(4) integrin expression as measured by analysis of Triton X-100-soluble cellular extracts. The results from integrin inhibition experiments indicate that basal migration on laminin-10 is mediated by alpha(3)beta(1) but not alpha(2)beta(1) nor alpha(6)beta(4) integrins. Alpha(3) blocking antibodies also inhibited EGF-stimulated chemokinetic migration of LIM1215 cells on laminin-10. However, in contrast to unstimulated cells, alpha(6) or beta(4) integrin-blocking antibodies inhibited the migration of EGF-stimulated cells by up to 50%. Taken together, these results support the cooperative role of EGF receptor and laminin-10 on colon cancer cell motility and suggest a critical role for both the alpha(3)beta(1) and the alpha(6)beta(4) integrins in this process.

Citing Articles

Integrin α3β1 Is Not Required for Onset of Dysplasia in Genetic Model of Colon Cancer but Promotes Motility of Colon Cancer Cells.

Ottaviano K, Subbaram S, Wu L, Stahl K, Mastrangelo A, Lee H Cancers (Basel). 2025; 17(3).

PMID: 39941740 PMC: 11815772. DOI: 10.3390/cancers17030371.


Laminin-integrin a6b4 interaction activates notch signaling to facilitate bladder cancer development.

Hao N, Yang D, Liu T, Liu S, Lu X, Chen L BMC Cancer. 2022; 22(1):558.

PMID: 35585515 PMC: 9118635. DOI: 10.1186/s12885-022-09645-7.


KRAS Mutants Upregulate Integrin β4 to Promote Invasion and Metastasis in Colorectal Cancer.

Choi S, Kim J, Chen C, Wu C, Marco M, Barriga F Mol Cancer Res. 2022; 20(8):1305-1319.

PMID: 35394541 PMC: 9357101. DOI: 10.1158/1541-7786.MCR-21-0994.


Evaluation of ITGA3 as a Biomarker of Progression and Recurrence in Papillary Thyroid Carcinoma.

Zhang G, Li B, Lin Y Front Oncol. 2022; 11:614955.

PMID: 35174063 PMC: 8841514. DOI: 10.3389/fonc.2021.614955.


Apoptosis induction by siRNA targeting integrin-β1 and regorafenib/DDAB-mPEG-PCL hybrid nanoparticles in regorafenib-resistant colon cancer cells.

Zhiani M, Mousavi M, Rostamizadeh K, Pirizadeh R, Osali A, Mennati A Am J Cancer Res. 2021; 11(4):1170-1184.

PMID: 33948352 PMC: 8085858.